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in Neuroﬁbromatosis Type 1
Is Antiplatelet Treatment Enough?Javier Molina-Martin de Nicolas, MD, Alfonso Jurado Roman, MD, Belen Rubio Alonso, MD, Julio Garcia Tejada, MDA 68-year-old woman was admitted for ananterolateral myocardial infarction (MI). Shehad neuroﬁbromatosis type 1 (NF-1) and 2
previous hospitalizations for non–ST-segment eleva-
tion MI, medically treated. In those episodes, aneu-
rysmal coronary arteries with fresh thrombus in left
anterior descending artery (LAD) were described.
Emergent coronary angiography (CA) revealed a
giant aneurysm in the mid-LAD with multiple small
fresh thrombi (Figures 1A to 1C, Online Videos 1, 2,
and 3). There were Thrombolysis In Myocardial
Infarction ﬂow grade 3 and no signiﬁcant stenosis.
Aneurysmal dilations without signiﬁcant stenosis
were also observed in the right coronary and circum-
ﬂex arteries (Figures 1A to 1D). Triple antiplatelet
therapy (aspirin, clopidogrel, abciximab [intracoro-
nary bolus and 12-h perfusion]) and anticoagulation
(enoxaparine 60 mg bid) were administered.
One week later, scheduled CA showed a complete
angiographic resolution of the thrombus (Figures 1E
and 1F, Online Videos 4 and 5). No percutaneous
coronary intervention (PCI) was performed. Given
that this episode was the third MI in aneurysmalFrom the Cardiology Department, University Hospital Doce de Octubre, Mad
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anticoagulation and double-antiplatelet therapy for
1 year. Fourteen months later, the patient remains
asymptomatic without any event.
Vascular manifestations of NF-1 comprise aneu-
rysmal and stenotic abnormalities that can affect
different arterial territories (1). Although affecting
coronary arteries is extremely rare, coronary aneu-
rysms have been described and can cause MI by
thrombosis, vasospasm, and stenosis (2). No con-
sensus exists regarding its treatment, and several
PCIs (thromboaspiration, stent implantation) and
antithrombotic regimens have been used (3). If TIMI
ﬂow grade 3 is preserved and no signiﬁcant stenosis
exists, a conservative management with antith-
rombotics and permanent anticoagulation may be the
best option and could reduce further events.
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FIGURE 1 Emergent and After Treatment Coronary Angiograms
(A to C, Online Videos 1, 2, and 3) Emergent coronary angiograms. (D to F, Online Videos 4 and 5) Scheduled coronary angiography 1 week later.
Arrows indicate the giant left anterior descending artery aneurysm. Asterisks indicate multiple small little fresh thrombi. Arrowheads indicate
aneurysmal dilations in the right coronary and circumﬂex arteries.
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